NCT01211093

Brief Summary

Whole body vibration has been found to be useful in promoting bone health, balance, and muscle performance in older adults. The overall aim of the proposed study is to determine whether whole body vibration (WBV) has immediate beneficial effect in neuromotor performance in patients with stroke. It is hypothesized that a single session of WBV will induce significant improvement in leg muscle strength in people with chronic stroke.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Nov 2009

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 17, 2010

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 29, 2010

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

November 28, 2012

Status Verified

November 1, 2012

Enrollment Period

3.4 years

First QC Date

September 17, 2010

Last Update Submit

November 26, 2012

Conditions

Keywords

vibrationmusclecerebrovascular accidentexerciserehabilitation

Outcome Measures

Primary Outcomes (1)

  • knee extension isokinetic strength

    2 weeks

Secondary Outcomes (4)

  • Muscle activity (electromyography) of knee extensors

    during treatment

  • knee extension isometric strength

    2 weeks

  • knee flexion isometric strength

    2 weeks

  • knee flexion isokinetic strength

    2 weeks

Study Arms (3)

High frequency whole body vibration

EXPERIMENTAL

This group will receive a single 10-minute session of WBV therapy. The frequency of the vibration signals will be set at 30Hz.

Procedure: High frequency whole body vibration

low frequency whole body vibration

ACTIVE COMPARATOR

This group will receive a single 10-minute session of WBV. The frequency of the vibration signals will be set at 20 Hz.

Procedure: Low frequency whole body vibration

Control

ACTIVE COMPARATOR

This group will stand on the same vibration platform for 10 minutes, but no vibration will be given.

Procedure: control

Interventions

1 single session (10 minutes) of whole body vibration therapy at 30 Hz

Also known as: Whole body vibration therapy (30Hz)
High frequency whole body vibration

1 single session of whole body vibration therapy at 20 Hz

Also known as: Whole body vibration therapy (20Hz)
low frequency whole body vibration
controlPROCEDURE

1 single session of standing on the vibration platform, with no vibration signals delivered.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a diagnosis of stroke
  • stroke onset \>6 months
  • \>18 years of age
  • \>able to walk for short distance independently with or without walking aid
  • able to understand simple verbal commands

You may not qualify if:

  • other neurological conditions
  • peripheral vascular disease
  • vestibular disorders
  • significant musculoskeletal disorders (e.g. rheumatoid arthritis)
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, China

RECRUITING

MeSH Terms

Conditions

StrokeMotor Activity

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Marco YC Pang, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ricky WK Lau, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 17, 2010

First Posted

September 29, 2010

Study Start

November 1, 2009

Primary Completion

April 1, 2013

Study Completion

July 1, 2013

Last Updated

November 28, 2012

Record last verified: 2012-11

Locations